Catalyst Pharma (CPRX) says CPP-115 gets FDA fast track designation
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Join SI Premium – FREE
Catalyst Pharma (Nasdaq: CPRX) says CPP-115 gets FDA fast track designation
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FDA approves Regeneron's Pasatru for rare bone disorder FOP
- AstraZeneca halts Phase III lung cancer trial after data review
- Gossamer Bio raises up to $250M in private placement for PAH drug
Create E-mail Alert Related Categories
FDA, Hot FDA News, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
